MannKind Stock (NASDAQ: MNKD) stock price, news, charts, stock research, profile.
You can purchase shares of MannKind (NASDAQ:MNKD) through any online brokerage.
Other companies in MannKind’s space includes: Centessa Pharmaceuticals (NASDAQ:CNTA), Xencor (NASDAQ:XNCR), SpringWorks Therapeutics (NASDAQ:SWTX), Protagonist Therapeutics (NASDAQ:PTGX) and Kiniksa Pharmaceuticals (NASDAQ:KNSA).
MannKind has a consensus price target of $8.29.
The stock price for MannKind (NASDAQ: MNKD) is $6.96 last updated November 13, 2024 at 4:21 PM EST.
There are no upcoming dividends for MannKind.
MannKind’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for MannKind.
MannKind is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.